Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors

Gili Kenet*, Uri Martinowitz

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Single-Dose Recombinant Activated Factor VII Therapy in Hemophilia Patients With Inhibitors'. Together they form a unique fingerprint.

Medicine & Life Sciences